Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2013 06:05 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides Third Quarter 2013 Corporate Update

Vitaros® on Track for European Launch in 2014 Company Provides Femprox® Update Company to Host Conference Call/Webcast Today at 9:00 AM ET SAN DIEGO, Nov. 13, 2013 (GLOBE...
November 13, 2013 06:00 ET | Source: Seelos Therapeutics, Inc.

Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries

SAN DIEGO, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), announced today that Apricus signed an exclusive license...
November 05, 2013 11:29 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Third Quarter 2013 Corporate Update Conference Call

SAN DIEGO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that it will hold a conference call to discuss its...
October 07, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Germany

First Topical, Fast-Acting, On-Demand Treatment for Erectile Dysfunction Approved in One of Europe's Largest Markets Apricus Remains On-Track to Announce Additional Vitaros® Partnering...
September 09, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Updates Presentation Time at the 2013 Stifel Nicolaus Healthcare Conference

SAN DIEGO, Sept. 9, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced a change in the Company's presentation time...
September 04, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 2013 Stifel Nicolaus Healthcare Conference

SAN DIEGO, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced that Richard Pascoe, Chief Executive...
August 29, 2013 16:15 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides Vitaros(R) Swissmedic Update

SAN DIEGO, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced that Swissmedic, the Agency for Therapeutic...
August 15, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Receives National Phase Approvals for Vitaros(R) in Ireland and the Netherlands

SAN DIEGO, Aug. 15, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced that the Irish Medicines Board and the...
August 12, 2013 06:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Reports Corporate Update

Vitaros® National Phase Approvals Granted in the United Kingdom and Sweden Company to Host Conference Call/Webcast Today at 9:00 AM ET SAN DIEGO, Aug. 12, 2013 (GLOBE NEWSWIRE) -- Apricus...
August 09, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Corporate Update Conference Call

SAN DIEGO, Aug. 9, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that it will hold a conference call to discuss...